retatrutide mental health vs. Tirzepatide: What's The Difference? – Forbes Retatrutide Significantly Reduces Visceral Fat

Chen S, Okahara F, Osaki N, Shimotoyodome A

This protective association persisted at two years, with a risk of 1.15% in the GLP-1 group compared to 1.39% in the control group (HR: 0.86)

In early clinical trials, participants taking Orforglipron experienced significant weight loss compared to those taking a placebo 1

Muscle Preservation Should Be Part of Every GLP-1 Conversation One of the biggest patient concerns with GLP-1 and next-generation obesity medications is muscle loss

Why is retatrutide more effective than semaglutide

While exciting, doctors stress that there are still side effects to consider, more research is needed, and this medication is not yet FDA-approved